About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 13608 record(s)
Req # A-2021-000427
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-102050-179, Virtual Healthcare Conference: How to Fix Canada’s PPE Supply Chain? Building a National Marketplace After COVID-19.Organization: Health Canada
November 2021
Req # A-2021-000507
Adverse Drug Reaction (ADR) for ALEMTUZUMAB. Report number: E2B_03394016.Organization: Health Canada
November 2021
Req # A-2021-000569
Adverse Drug Reaction (ADR) for INSULIN GLARGINE. Report number: E2B_03313409.Organization: Health Canada
November 2021
Req # A-2021-000886
Adverse Drug Reaction (ADR) for Hizentra. Report number: E2B_03743938.Organization: Health Canada
November 2021
Req # A-2021-000998
Adverse Drug Reactions (ADRs) for FLUDARABINE PHOSPHATE. Report numbers: E2B_03817011, E2B_03542554.Organization: Health Canada
November 2021
Req # A-2021-001003
Adverse Drug Reactions (ADRs) for METRONIDAZOLE. Report numbers: E2B_04017773, E2B_04415252, E2B_03992837.Organization: Health Canada
November 2021
Req # A-2021-001020
Adverse Drug Reaction (ADR) for IRBESARTAN. Report number: E2B_03595491.Organization: Health Canada
November 2021
Req # A-2021-001114
Adverse Drug Reaction (ADR) for LEFLUNOMIDE. Report number: E2B_02615649.Organization: Health Canada
November 2021
Req # A-2021-02531
Copy of briefing note/memoF-1194116 (HR) Mandatory Cash-Out of Excess LeaveOrganization: Immigration, Refugees and Citizenship Canada
November 2021
Req # A-2021-02545
Copy of briefing note/memo F-1196785 (FOB) Proactive Disclosure : Travel Expenses for August, à l’exclusion des documents confidentiels du Cabinet qui nécessiteraient une consultation pour être confirmés.Organization: Immigration, Refugees and Citizenship Canada
November 2021